| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/19/2008 | CA2578891A1 Medicaments for fungal infections |
| 08/19/2008 | CA2442135C Methods to culture circovirus |
| 08/19/2008 | CA2351618C Protein amsh and cdna thereof |
| 08/19/2008 | CA2336808C Method for purifying hemoglobin |
| 08/19/2008 | CA2241172C Episomal vector and uses thereof |
| 08/19/2008 | CA2120731C Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 08/14/2008 | WO2008098216A2 Compositions and methods to prevent cancer with cupredoxins |
| 08/14/2008 | WO2008098198A2 Alkane oxidation by modified hydroxylases |
| 08/14/2008 | WO2008098169A2 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
| 08/14/2008 | WO2008098145A1 Methods for modulating antigen-specific b cell responses |
| 08/14/2008 | WO2008097875A1 Novel methods for treating neurodegenerative disorders |
| 08/14/2008 | WO2008097812A1 Toxoplasma gondii oocyst protein |
| 08/14/2008 | WO2008097585A2 Mutations in human ubiad1 |
| 08/14/2008 | WO2008097541A2 Variants derived from actriib and uses therefor |
| 08/14/2008 | WO2008097197A1 Putative cytokinin receptor and methods for use thereof |
| 08/14/2008 | WO2008097016A1 Modified flagellin improved toll-like receptor 5 stimulating activity |
| 08/14/2008 | WO2008096994A1 Proteins activating pro-phenoloxidase system and genes encoding the same |
| 08/14/2008 | WO2008096865A1 Therapeutic agent for disease induced by dysfunction or degeneration of organ |
| 08/14/2008 | WO2008096837A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family with attenuated expression of the tolc gene |
| 08/14/2008 | WO2008096831A1 Therapeutic agent for cancer |
| 08/14/2008 | WO2008096816A1 Angiogenesis inducer and polypeptide for use in the angiogenesis inducer |
| 08/14/2008 | WO2008096814A1 Novel polypeptide and antibacterial agent comprising the same as active ingredient |
| 08/14/2008 | WO2008096811A1 Attenuated minus-stranded rna virus |
| 08/14/2008 | WO2008096781A1 Betacellulin mutein |
| 08/14/2008 | WO2008096767A1 Protein marker for hepatocellular cancer, and method and apparatus for detection of hepatocellular cancer using the same |
| 08/14/2008 | WO2008096242A1 Antibodies specific for varicella zoster virus |
| 08/14/2008 | WO2008095826A1 Method to obtain salt tolerance in eukaryotic cells |
| 08/14/2008 | WO2008095677A1 Recombinant antigens of human cytomegalovirus (hcmv) |
| 08/14/2008 | WO2008095299A1 Synthetic hiv-2 envelope gene that lead to optimized expression in bacteria for use in hiv-2 antibody immunoassays |
| 08/14/2008 | WO2008095298A1 Synthetic hiv-i envelope gene that lead to optimized expression in bacteria for use in hiv-i antibody immunoassays |
| 08/14/2008 | WO2008076367A3 Polymer-protein substrates for immunosorbent fluorescence assays |
| 08/14/2008 | WO2008071755A3 Casein-derived peptides having anxiolytic activity |
| 08/14/2008 | WO2008065543A3 Modified soluble fgf receptor fc fusions with improved biological activity |
| 08/14/2008 | WO2008065543A2 Modified soluble fgf receptor fc fusions with improved biological activity |
| 08/14/2008 | WO2008062383A3 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 08/14/2008 | WO2008060785A3 Prevention of tissue ischemia, related methods and compositions |
| 08/14/2008 | WO2008055972A3 N-terminal pegylated prolactin receptor molecules |
| 08/14/2008 | WO2008045489A9 Glucoamylase variants with altered properties |
| 08/14/2008 | WO2008034648A8 Process for the production of a fine chemical |
| 08/14/2008 | WO2008015383A3 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
| 08/14/2008 | WO2008011574A3 Bacillus thuringiensis toxin with anti-lepidopteran activity |
| 08/14/2008 | WO2007146269A3 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 08/14/2008 | WO2007135420A3 Defective interfering virus |
| 08/14/2008 | WO2007129218A3 Tpeptides for detecting or inducing production of antibodies against human papilloma virus, l1 protein or peptides from this protein. |
| 08/14/2008 | WO2007119891A9 A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF THE fhuA GENE |
| 08/14/2008 | WO2007112048A3 Methods and apparatuses for coating a lesion |
| 08/14/2008 | WO2007060213A3 Erythropoietin polypeptides and uses thereof |
| 08/14/2008 | US20080196126 Transgenic Plants Containing a Dehydrin Gene |
| 08/14/2008 | US20080196120 Genes Involved in Plant Fibre Development |
| 08/14/2008 | US20080196114 Recombinant rodent comprising modified repulsive guidance molecule gene for use in identifying modulator for treatment and prevention of vision defects |
| 08/14/2008 | US20080196113 Lipocalin Protein |
| 08/14/2008 | US20080194800 Human Receptor Proteins; Related Reagents and Methods |
| 08/14/2008 | US20080194799 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 08/14/2008 | US20080194797 Leucine-based motif and clostridial neurotoxins |
| 08/14/2008 | US20080194682 administering inhibitors of endopeptidase such as thiorphan or candoxatril, to effect bone elongation; achondroplasia |
| 08/14/2008 | US20080194577 Antiallergens; asthma; autoimmune disease; pruritius; antiarthritic agents |
| 08/14/2008 | US20080194511 Encoding somatoliberin (GHRH) and comprising a eukaryotic promoter; a 5' untranslated region, a codon-optimized-eukaryotic therapeutic gene sequence, and a polyadenylation signal; plasmid mediated gene supplementation |
| 08/14/2008 | US20080194505 Point mutations; antibodies; fusion proteins |
| 08/14/2008 | US20080194486 Novel Anti-Obesity Agents |
| 08/14/2008 | US20080194484 Truncated Motilin-Like (TML) peptides; use modulating contractility in duodenum or jejunum tissue and pancreatic secretion of hormones and digestive enzymes |
| 08/14/2008 | US20080194482 VPAC2 receptor peptide agonists of given amino acid sequences; PACAP-preferring type 2 (PAC2) receptor; VIP-shared type 2 receptors (VPAC2); induce insulin secretion from the pancreas only in the presence of high blood glucose levels; side effect reduction; diabetes |
| 08/14/2008 | US20080194481 Albumin Fusion Proteins |
| 08/14/2008 | US20080194480 Polypeptide for reducing the growth rate of cancer cells; polypeptide of given sequence that is down-regulated in cancer |
| 08/14/2008 | US20080194477 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 08/14/2008 | US20080194475 mutant erythropoietin (EPO) having improved stability as measured by a ratio of the ability of an EPO variant to bind the EPO receptor in the presence of dithiothreitol (DTT), in a radioimmunoassay, versuses the ability in the absence of DTT in the same radioimmunoassay |
| 08/14/2008 | US20080194460 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders |
| 08/14/2008 | US20080194020 Methods For Producing Dendritic Cells That Have Acquired Ctl-Inducing Ability |
| 08/14/2008 | US20080194004 Point mutations; antibodies; fusion proteins |
| 08/14/2008 | US20080193996 Methods for separating molecules |
| 08/14/2008 | US20080193976 Pseudomonas Exotoxin A Cd4+T-Cell Epitopes |
| 08/14/2008 | US20080193974 Expression vector comprising nucleotoide sequences coding signal sequences which direct proteins to periplasmic compartment; improving exogenous expression of heterologous polypeptides |
| 08/14/2008 | US20080193972 Gene Rcs 25 |
| 08/14/2008 | US20080193971 Using transferrin digestion as tool to generate meningococcal polypeptide products for use in preparing vaccine to prevent or treat meningitis and/or septic shock |
| 08/14/2008 | US20080193969 Using microorganismal bioreactor to ferment oxygen-binding protein |
| 08/14/2008 | US20080193951 MN Gene and Protein |
| 08/14/2008 | US20080193947 Complementary Peptides For Beta-Amyloid 29-42 Peptide |
| 08/14/2008 | US20080193939 Corneodesmosin based test and model for inflammatory disease |
| 08/14/2008 | US20080193924 Reacting astemizole with potassium channel moderators; complexing; calibration; kits |
| 08/14/2008 | US20080193920 Methods and systems for producing recombinant viral antigens |
| 08/14/2008 | US20080193510 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 08/14/2008 | US20080193488 Variant Polypeptide and Screening Assay |
| 08/14/2008 | US20080193486 Live, Oral Vaccine for Protection Against Shigella Dysenteriae Serotype 1 |
| 08/14/2008 | US20080193480 Infectious Bursal Disease Virus antigenic isolates and vaccines |
| 08/14/2008 | US20080193475 Growing strain of Corynebacterium diphtheria in medium in fermenter under conditions of agitation sufficient to maintain homogenous culture and limited aeration; high yields; prevention of bacterial disease such as C. diphtheriae disease |
| 08/14/2008 | US20080193471 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| 08/14/2008 | US20080193469 Contraceptives Based on Sp22 and Sp22 Antibodies |
| 08/14/2008 | US20080193467 Dendritic cell potentiation |
| 08/14/2008 | US20080193458 125p5c8: tissue specific protein highly expressed in various cancers |
| 08/14/2008 | US20080193457 Major histocompatibility complex peptide for use in treatment and prevention of rheumatoid arthritis (RA) |
| 08/14/2008 | US20080193454 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/14/2008 | US20080193426 Increasing homing of CD34 by administering chemokines, fusion protein; irradiation, cyclophosphamide or 5-fluorouracil; interleukins; Gaucher disease |
| 08/14/2008 | US20080193417 DNA encoding insecticidal CRY9Fa bacillus thuringiensis proteins and recombinant hosts expressing same |
| 08/14/2008 | US20080193389 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| 08/14/2008 | CA2685437A1 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
| 08/14/2008 | CA2678145A1 Methods and devices for diagnosis of appendicitis |
| 08/14/2008 | CA2677803A1 Compositions and methods to prevent cancer with cupredoxins |
| 08/14/2008 | CA2677659A1 Attenuated minus-stranded rna virus |
| 08/14/2008 | CA2677544A1 Peptidic and non peptidic ligands for immunodetection of the receptor for urotensin ii |
| 08/14/2008 | CA2677455A1 Recombinant antigens of human cytomegalovirus (hcmv) |
| 08/14/2008 | CA2677371A1 Antibodies specific for varicella zoster virus |